BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Transgene Biotek Ltd Industry :  Miscellaneous
BSE Code
526139
ISIN Demat
INE773D01018
Book Value (Rs)
-1.2142009
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
19
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
10
Back
Transgene Biotek reports consolidated net loss of Rs 0.46 crore in the March 2026 quarter
30-May-26   Hrs IST

Net Loss of Transgene Biotek reported to Rs 0.46 crore in the quarter ended March 2026 as against net loss of Rs 0.71 crore during the previous quarter ended March 2025. Sales declined 37.50% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.65 crore in the year ended March 2026 as against net loss of Rs 0.68 crore during the previous year ended March 2025. Sales declined 19.23% to Rs 0.21 crore in the year ended March 2026 as against Rs 0.26 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.050.08 -38 0.210.26 -19
OPM %-560.00-675.00 --257.14-430.77 -
PBDT-0.41-0.69 41 -1.45-0.58 -150
PBT-0.46-0.71 35 -1.65-0.68 -143
NP-0.46-0.71 35 -1.65-0.68 -143

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)